NASDAQ:FULC | Income Statement | Fulcrum Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$12.44M$29.31M-$29.31M-$26.18M-$0.34-$0.3476,264,00076,264,000
2026-03-31$14.08M$22.19M-$22.19M-$18.89M-$0.25-$0.2576,215,00076,215,000
2025-12-31$0.00$15.42M$22.69M-$22.69M-$20.33M-$0.31-$0.31-62,473,645-62,473,645
2025-09-30$0.00$14.3M$21.86M-$21.86M-$19.6M-$0.31-$0.3162,597,00062,597,000
2025-06-30$0.00$12.99M$19.82M-$19.82M-$17.3M-$0.28-$0.2862,544,00062,544,000
2025-03-31$13.4M$20.4M-$20.4M-$17.66M-$0.28-$0.2862,479,00062,479,000
2024-12-31$0.00$11.71M$19.43M-$19.43M-$16.57M-$0.27-$0.27-62,138,016-63,626,016
2024-09-30$0.00$14.64M$25.13M-$25.13M-$21.7M-$0.35-$0.3562,409,00062,409,000
2024-06-30$80M$17.26M$27.51M$52.49M$55.41M$0.89$0.8762,205,00063,587,000
2024-03-31$0.00$19.77M$29.83M-$29.83M-$26.87M-$0.43-$0.4361,984,00061,984,000
2023-12-31$871,000.00$19M$28.86M-$27.99M-$24.76M-$0.40-$0.40-61,059,690-61,059,690
2023-09-30$759,000.00$18.24M$28.2M-$27.44M-$24.02M-$0.39-$0.3961,823,00061,823,000
2023-06-30$880,000.00$17.85M$28.17M-$27.29M-$23.78M-$0.38-$0.3861,794,00061,794,000
2023-03-31$295,000.00$16.72M$28.24M-$27.94M-$24.78M-$0.41-$0.4159,72259,722
2022-12-31$685,000.00$18.57M$28.66M-$27.97M-$26.14M-$0.47-$0.472,3882,388
2022-09-30$1.18M$15.37M$25.54M-$24.36M-$23.74M-$0.51-$0.5146,21346,213
2022-06-30$1.88M$25.02M$36.12M-$34.24M-$34.07M-$0.83-$0.8340,89040,890
2022-03-31$2.59M$17.83M$28.59M-$26M-$25.93M-$0.64-$0.6440,64440,644
2021-12-31$11.36M$18.91M$28.62M-$23.56M-$23.48M-$0.58-$0.581,7581,758
2021-09-30$4.94M$17.08M$25.71M-$20.77M-$20.72M-$0.57-$0.5736,60636,606
2021-06-30$4.38M$17.38M$24.06M-$19.68M-$19.65M-$0.60-$0.6032,63632,636
2021-03-31$4.79M$16.33M$21.83M-$17.04M-$17M31,510,000
2020-12-31$4.23M$16.15M$22.01M-$17.79M-$17.72M733
2020-09-30$1.85M$15.64M$20.95M-$19.1M-$18.96M27,261
2020-06-30$2M$12.78M$17.92M-$15.92M-$15.69M23,854
2020-03-31$750,000.00$14.48M$19.55M-$18.8M-$18.45M22,719
2019-12-31$12.09M$16.49M-$16.49M-$16.12M3,913
2019-09-30$13.5M$17.01M-$17.01M-$16.54M17,785
2019-06-30$10.86M$13.49M-$13.49M-$13.17M1,787
2019-03-31$34.63M$37.23M-$37.23M-$36.84M1,642
2018-12-31$6.86M$9.25M-$9.25M-$8.86M77
2018-09-30$6.96M$9.09M-$9.09M-$8.94M1,337
2018-06-30$5.79M$7.85M-$7.85M-$7.85M1,186
2018-03-31-$6.94M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$0.00$56.1M$84.77M-$84.77M$0.00-$74.88M-$1.18-$1.1863,35563,355
2024-12-31$80M$63.39M$101.9M-$21.9M$0.00-$9.73M-$0.16-$0.1661,98461,984
2023-12-31$2.81M$71.8M$113.47M-$110.66M-$97.34M-$1.59-$1.5961,31061,310
2022-12-31$6.34M$76.78M$118.9M-$112.56M-$109.87M-$2.44-$2.4444,99144,991
2021-12-31$19.16M$69.7M$100.22M-$81.05M-$80.85M-$2.29-$2.2935,36135,361
2020-12-31$8.82M$59.04M$80.43M-$71.61M-$70.82M25,354
2019-12-31$71.07M$84.22M-$84.22M-$82.68M11,046
2018-12-31$25.18M$33.5M-$33.5M-$32.59M1,257